HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/1/L278    most recent 00111.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by McWhinnie, R. Articles by Bai, T. R. Search for Related Content PubMed PubMed Citation Articles by McWhinnie, R. Articles by Bai, T. R.

Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells

¹The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia; and ²Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada

Submitted 26 March 2006 ; accepted in final form 14 August 2006

Endothelin-1 (ET-1), a G protein-coupled receptor-activating peptide, is increased in airway epithelium, plasma, and bronchoalveolar lavage fluid of asthmatic patients. We hypothesized that ET-1 may contribute to the increased airway smooth muscle mass found in severe asthma by inducing hypertrophy and inhibiting apoptosis of smooth muscle cells. To investigate this hypothesis, we determined that treatment of primary human bronchial smooth muscle cells with ET-1 dose dependently [10^–11-10^–7 M] inhibited the apoptosis induced by serum withdrawal. ET-1 treatment also resulted in a significant increase in total protein synthesis, mediated through both ET_A and ET_B receptors, cell size, as well as increased expression of myosin heavy chain, -smooth muscle actin, and calponin. ET-1-induced hypertrophy was accompanied by activation of JAK1/STAT-3 and MAPK1/2 (ERK1/2) cell signaling pathways. Inhibition of JAK1/STAT-3 pathways by piceatannol or ERK1/2 by the MAPK/ERK kinase 1/2 inhibitor U0126 blunted the increase in total protein synthesis. The hypertrophic effect of ET-1 was equivalent to that of the gp130 cytokine oncostatin M and greater than that induced by cardiotrophin-1. ET-1 induced release of IL-6 but not IL-11, leukemia inhibitory factor, oncostatin M, or cardiotrophin-1, although treatment of cells with IL-6 alone did not induce hypertrophy. These results suggest that ET-1 is a candidate mediator for the induction of increased smooth muscle mass in asthma and identify signaling pathways activated by this mediator.

interleukin-6; oncostatin M; signal transducer and activator of transcription 3; extracellular signal-regulated kinase 1/2; asthma

This article has been cited by other articles:

				N. K. Malavia, C. B. Raub, S. B. Mahon, M. Brenner, R. A. Panettieri Jr., and S. C. George Airway Epithelium Stimulates Smooth Muscle Proliferation Am. J. Respir. Cell Mol. Biol., September 1, 2009; 41(3): 297 - 304. [Abstract] [Full Text] [PDF]

				F. Drakopanagiotakis, A. Xifteri, V. Polychronopoulos, and D. Bouros Apoptosis in lung injury and fibrosis Eur. Respir. J., December 1, 2008; 32(6): 1631 - 1638. [Abstract] [Full Text] [PDF]

				J. K. Bentley and M. B. Hershenson Airway Smooth Muscle Growth in Asthma: Proliferation, Hypertrophy, and Migration Proceedings of the ATS, January 1, 2008; 5(1): 89 - 96. [Abstract] [Full Text] [PDF]

				S. S. An, T. R. Bai, J. H. T. Bates, J. L. Black, R. H. Brown, V. Brusasco, P. Chitano, L. Deng, M. Dowell, D. H. Eidelman, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma Eur. Respir. J., May 1, 2007; 29(5): 834 - 860. [Abstract] [Full Text] [PDF]